Pharmalix | Pharma Intelligence & Healthcare Platform

Signup Today

Pharmalix | Pharma Intelligence & Healthcare Platform


India’s #1 Pharma Intelligence Platform

Pharma Intelligence.
Decoded.

From drug discovery to post-market surveillance — comprehensive intelligence across 12,000+ drugs, 50,000+ trials, and 50+ regulatory agencies.

12,000+
Drugs Tracked
50,000+
Clinical Trials
25,000+
Professionals

● Live Intelligence Feed
FDA Approval
New NDA approved for CAR-T therapy in relapsed B-cell lymphoma
2 hours ago · Oncology

CDSCO Alert
3 new generic drug approvals granted under expedited review pathway
5 hours ago · Regulatory

Trial Update
Phase III readout: Oral GLP-1 hits primary endpoint vs. semaglutide
8 hours ago · Endocrinology

Market Signal
India biosimilars market forecast to reach ₹38,000 Cr by 2028
12 hours ago · Market Research

Intelligence sourced from global regulatory authorities

FDA
EMA
CDSCO
PMDA
TGA
MHRA
WHO
+43 more

Intelligence Suite

Everything You Need to Lead in Pharma

Six integrated intelligence modules. One unified platform. Built for India’s pharma ecosystem.

💊

Drug Intelligence

12,000+ drug profiles — molecular data, mechanisms, pharmacokinetics, real-world evidence, and Indian brand name mapping.

Explore Database →

🔬

Clinical Analytics

Monitor 50,000+ trials globally. Analyze endpoints, patient populations, protocols, and outcomes. Includes CTRI coverage.

View Analytics →

📋

Regulatory Affairs

Real-time alerts from FDA, EMA, CDSCO, PMDA & 47 more. Approval tracking, safety communications, and guidance updates.

Track Regulatory →

📊

Market Intelligence

500+ research reports. Market sizing, competitive landscapes, pipeline assessments, and India pharma investment intelligence.

Access Reports →

🤖

Healthcare AI

AI-powered drug discovery insights, predictive clinical outcome models, intelligent literature screening and summarization.

See AI Tools →

🏥

Healthcare Data

Epidemiology data, disease burden analytics, treatment protocols, and healthcare system benchmarking across India and globally.

Explore Data →

Why Pharmalix

The Intelligence Platform Built for Pharma Professionals

Pharmalix aggregates, curates, and delivers actionable intelligence from thousands of global sources — with unmatched India-specific depth. Every data point is verified. Every insight is actionable.

✓

Real-time data from 50+ regulatory agencies worldwide

✓

12,000+ structured drug profiles updated daily

✓

AI-assisted literature review and summarization

✓

Deep India focus: CDSCO, CTRI, and IPC coverage

✓

Trusted by 25,000+ healthcare professionals

Learn About Pharmalix →

12K+
Drug Profiles

50K+
Clinical Trials

180+
Countries

500+
Reports

Coverage

Therapeutic Areas We Cover

Deep intelligence across all major disease areas — from common conditions to rare diseases.

🎯 Oncology
❤️ Cardiology
🧠 Neurology
🩺 Endocrinology
🦠 Rare Diseases
🛡️ Immunology
🦠 Infectious Diseases
💨 Respiratory
🫁 Gastroenterology
✨ Dermatology
💉 Biosimilars
💊 Generics
🧬 Gene Therapy
🦴 Rheumatology

Testimonials

Trusted by Pharma Leaders

“

Pharmalix has completely transformed how our regulatory team tracks CDSCO submissions. The real-time alerts alone save us hours every week.

DR
Dr. Priya Rajan
Head, Regulatory Affairs · Sun Pharmaceutical

“

The clinical trial analytics module is exceptional. We use it to benchmark our protocols against global standards before submitting our IND.

AK
Arjun Krishnamurthy
VP Clinical Operations · Cipla Limited

“

For our investment thesis in Indian pharma, Pharmalix’s market research reports are indispensable. Depth and accuracy that’s hard to find elsewhere.

SM
Siddharth Mehta
Partner, Healthcare Investments · Healthquad

Weekly Intelligence

Stay Ahead in Pharma Intelligence

Weekly drug approvals, regulatory updates, and clinical trial breakthroughs — delivered every Thursday morning.


Trusted by 25,000+ pharma professionals. No spam. Unsubscribe anytime.